期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
沉默NCAPG表达抑制肺腺癌细胞增殖作用及相关机制 被引量:1
1
作者 孙玲艳 孟兰霞 +1 位作者 张雨岑 董玉金 《社区医学杂志》 CAS 2022年第22期1264-1270,共7页
目的探讨肺腺癌细胞中非染色体结构维持蛋白复合体I G亚基(NCAPG)的表达对细胞增殖能力的影响及潜在的相关机制,为肺腺癌探索新的治疗靶点提供理论数据。方法采用qRT-PCR和蛋白质印迹法检测肺腺癌细胞中NCAPG表达,分别以siRNA序列及阴... 目的探讨肺腺癌细胞中非染色体结构维持蛋白复合体I G亚基(NCAPG)的表达对细胞增殖能力的影响及潜在的相关机制,为肺腺癌探索新的治疗靶点提供理论数据。方法采用qRT-PCR和蛋白质印迹法检测肺腺癌细胞中NCAPG表达,分别以siRNA序列及阴性对照转染肺腺癌A549细胞株。观察组细胞转染siRNA,对照组细胞转染对照序列。采用CCK-8实验、BrdU实验,克隆形成实验、Transwell小室法等体外实验检测2组细胞增殖、侵袭能力变化;体内实验检测裸鼠皮下移植瘤增殖能力影响;进一步采用流式细胞术、蛋白质印迹法检测细胞周期及相关蛋白的表达。结果NCAPG在肺腺癌细胞株中高表达。沉默NCAPG表达后肺腺癌细胞NCAPG表达在mRNA及蛋白水平均降低。CCK-8实验及BrdU实验结果显示观察组细胞活性及增殖能力降低,F=82.105,P=0.001;克隆形成实验结果:观察组细胞形成菌落数为113.26±10.37,对照组为809.63±19.45,差异有统计学意义,F=112.762,P<0.001;Transwell实验结果显示:观察组细胞组侵入到下室的阳性细胞数为115.63±18.42,对照组为582.42±21.17,差异有统计学意义,F=97.347,P<0.001。体内实验显示注入转染siNCAPG的A549细胞组裸鼠皮下移植肿瘤增长减慢、体积及质量均减小;流式细胞术检测到观察组细胞G1期比例为(70.80±0.23)%,对照组为(56.40±0.41)%,差异有统计学意义,F=58.625,P=0.032;观察组细胞周期蛋白cyclinD1及细胞周期蛋白依赖性激酶CDK4、CDK6的表达下调,而细胞周期蛋白依赖性激酶抑制因子p21和p27表达上调。结论沉默NCAPG表达可能通过调控cyclin-CDK-CKI网络阻滞肺腺癌细胞周期由G1期向S期转化,进而抑制肿瘤细胞增殖、侵袭、致瘤能力。其可能成为肺腺癌治疗新的靶点。 展开更多
关键词 非染色体结构维持蛋白复合体I G亚基 小干扰核糖核酸 BrdU实验 流式细胞术 A549细胞
原文传递
A candidate protective factor in amyotrophic lateral sclerosis:heterogenous nuclear ribonucleoprotein G 被引量:2
2
作者 Fang Yang Wen-Zhi Chen +2 位作者 Shi-Shi Jiang Xiao-Hua Wang Ren-Shi Xu 《Neural Regeneration Research》 SCIE CAS CSCD 2023年第7期1527-1534,共8页
Heterogenous nuclear ribonucleoprotein G is down-regulated in the spinal cord of the Tg(SOD1*G93A)1Gur(TG)amyotrophic lateral sclerosis mouse model.However,most studies have only examined heterogenous nuclear ribonucl... Heterogenous nuclear ribonucleoprotein G is down-regulated in the spinal cord of the Tg(SOD1*G93A)1Gur(TG)amyotrophic lateral sclerosis mouse model.However,most studies have only examined heterogenous nuclear ribonucleoprotein G expression in the amyotrophic lateral sclerosis model and heterogenous nuclear ribonucleoprotein G effects in amyotrophic lateral sclerosis pathogenesis such as in apoptosis are unknown.In this study,we studied the potential mechanism of heterogenous nuclear ribonucleoprotein G in neuronal death in the spinal cord of TG and wild-type mice and examined the mechanism by which heterogenous nuclear ribonucleoprotein G induces apoptosis.Heterogenous nuclear ribonucleoprotein G in spinal cord was analyzed using immunohistochemistry and western blotting,and cell proliferation and proteins(TAR DNA binding protein 43,superoxide dismutase 1,and Bax)were detected by the Cell Counting Kit-8 and western blot analysis in heterogenous nuclear ribonucleoprotein G siRNA-transfected PC12 cells.We analyzed heterogenous nuclear ribonucleoprotein G distribution in spinal cord in the amyotrophic lateral sclerosis model at various time points and the expressions of apoptosis and proliferation-related proteins.Heterogenous nuclear ribonucleoprotein G was mainly localized in neurons.Amyotrophic lateral sclerosis mice were examined at three stages:preonset(60-70 days),onset(90-100 days)and progression(120-130 days).The number of heterogenous nuclear ribonucleoprotein G-positive cells was significantly higher in the anterior horn of the lumbar spinal cord segment of TG mice at the preonset stage than that of control group but lower than that of the control group at the onset stage.The number of heterogenous nuclear ribonucleoprotein G-positive cells in both central canal and surrounding gray matter of the whole spinal cord of TG mice at the onset stage was significantly lower than that in the control group,whereas that of the lumbar spinal cord segment of TG mice was significantly higher than that in the control group at preonset stage and significantly lower than that in the control group at the progression stage.The numbers of heterogenous nuclear ribonucleoprotein G-positive cells in the posterior horn of cervical and thoracic segments of TG mice at preonset and progression stages were significantly lower than those in the control group.The expression of heterogenous nuclear ribonucleoprotein G in the cervical spinal cord segment of TG mice was significantly higher than that in the control group at the preonset stage but significantly lower at the progression stage.The expression of heterogenous nuclear ribonucleoprotein G in the thoracic spinal cord segment of TG mice was significantly increased at the preonset stage,significantly decreased at the onset stage,and significantly increased at the progression stage compared with the control group.heterogenous nuclear ribonucleoprotein G expression in the lumbar spinal cord segment of TG mice was significantly lower than that of the control group at the progression stage.After heterogenous nuclear ribonucleoprotein G gene silencing,PC12 cell survival was lower than that of control cells.Both TAR DNA binding protein 43 and Bax expressions were significantly increased in heterogenous nuclear ribonucleoprotein G-silenced cells compared with control cells.Our study suggests that abnormal distribution and expression of heterogenous nuclear ribonucleoprotein G might play a protective effect in amyotrophic lateral sclerosis development via preventing neuronal death by reducing abnormal TAR DNA binding protein 43 generation in the spinal cord. 展开更多
关键词 amyotrophic lateral sclerosis Bax heterogenous nuclear ribonucleoprotein G heterogenous nuclear ribonucleoprotein g-sirna neuron death superoxide dismutase 1 TAR DNA binding protein 43 TG(SOD1*G93A)1Gur mice
暂未订购
针对HLA-G的siRNA的载体构建与表达及效应检测 被引量:1
3
作者 陈建辉 姚元庆 +2 位作者 侯开波 雷迎峰 尹文 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2007年第5期409-412,共4页
目的构建针对HLA-G的siRNA的表达载体,研究其对NK细胞杀伤效应的影响。方法构建针对HLA-G的siRNA真核表达质粒pSuppressor-U6-neo-HLA-G,转染JEG-3滋养细胞系。采用RT-PCR、Western blot检测转染的JEG-3细胞中HLA-G的表达水平。将NK-92M... 目的构建针对HLA-G的siRNA的表达载体,研究其对NK细胞杀伤效应的影响。方法构建针对HLA-G的siRNA真核表达质粒pSuppressor-U6-neo-HLA-G,转染JEG-3滋养细胞系。采用RT-PCR、Western blot检测转染的JEG-3细胞中HLA-G的表达水平。将NK-92MI细胞(效应细胞)与滋养细胞(靶细胞)共同培养,以LDH释放法观察不同效靶比例时NK-92MI细胞对靶细胞的杀伤效应。结果NK-92MI细胞对转染针对HLA-G的siRNA的JEG-3细胞的杀伤作用较未转染细胞明显升高(P<0.001)。结论针对HLA-G的SiRNA增加NK细胞对滋养细胞的杀伤,HLA-G具有保护滋养细胞免受NK细胞杀伤的作用。 展开更多
关键词 HLA-G SIRNA
原文传递
新型纳米材料HPC-g-PDMAEMA作为基因载体的研究
4
作者 李文斌 赵晨 +1 位作者 袁伟 马洁 《中国药学杂志》 CAS CSCD 北大核心 2010年第14期1080-1084,共5页
目的研究新型纳米载体HPC-g-PDMAEMA(HPD)对于不同肿瘤细胞系的转染能力,评价其在基因治疗及研究中的作用,并且初步探索HPD对于siRNA的运载能力。方法 HPD和脂质体2000(Lipo 2K)运载绿色荧光蛋白(GFP)质粒,分别转染MCF7、973、JF305 3... 目的研究新型纳米载体HPC-g-PDMAEMA(HPD)对于不同肿瘤细胞系的转染能力,评价其在基因治疗及研究中的作用,并且初步探索HPD对于siRNA的运载能力。方法 HPD和脂质体2000(Lipo 2K)运载绿色荧光蛋白(GFP)质粒,分别转染MCF7、973、JF305 3种肿瘤细胞系,采用流式细胞仪检测其转染效率;HPD和Lipo 2K运载针对GADPH的siRNA,转染MCF7,利用RT-PCR检测其RNA转染效率。结果对于MCF7细胞,HPD的DNA转染效率高于Lipo 2K;对于973细胞,二者转染效率相近;对于JF305细胞,HPD转染效率低于Lipo 2K。在MCF7细胞中,利用HPD进行RNA转染,效率低于Lipo 2K。结论对于不同的肿瘤细胞系,可以采用不同的基因载体进行转染,从而提高转染效率。 展开更多
关键词 HPC-g-PDMAEMA 脂质体2000 绿色荧光蛋白质粒 GADPH SIRNA
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部